For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

Recent research confirms that aluminum in childhood vaccines does not increase the risk of autoimmune, allergic or ...

STRATA Skin Sciences(NASDAQ:SSKN) reported its second-quarter 2025 results on August 13, 2025, highlighting significant developments in reimbursement expansion, ongoing litigation, and commercial ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, ...

AbbVie has shared promising top-line results from a late-stage study of its JAK inhibitor Rinvoq (upadacitinib) in severe ...

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory ...

Research and development expense (GAAP) rose approximately 65% year over year in Q2 2025 as clinical trials advanced. Net income (GAAP) shifted from $14.8 million in Q2 2024 to a net loss of $12.9 ...

Q2 2025 Earnings Call Transcript August 11, 2025 Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

STRATA Skin Sciences' Q2 2025 earnings call reveals CPT code expansion tripling patient reach, driving growth potential amid legal, tariff, ...

US and Canada probiotic food market US & Canada probiotic food market grows as consumers embrace gut health, functional foods, and innovati ...